<DOC>
	<DOCNO>NCT01068795</DOCNO>
	<brief_summary>The risk venous thromboembolism increase pregnancy . Thrombophilia whether genetic acquire , hypercoagulable disorder may increase risk venous thromboembolic event . Clinically , event present maternal deep vein thrombosis pulmonary embolus . Thrombophilias also associate adverse fetal outcome include intrauterine growth restriction , intrauterine fetal death , severe preeclampsia , placental abruption recurrent abortion . Pregnant woman experience one complication advise examined presence genetic acquire form thrombophilia . Low molecular weight heparin prophylaxis , anticoagulant , advise pregnant woman history thromboembolism , many expert recommend prophylaxis pregnant patient know thrombophilia history adverse pregnancy outcomes associate hypercoagulable state . Physiologic change normal pregnancy , include weight gain , increase renal clearance volume distribution , may decrease availability low molecular weight heparin ( Enoxaparin Dalteparin ) , produce less predictable response pregnant woman compare nonpregnant woman . There clear recommendation use prophylactic low molecular weight heparin pregnancy . Clinicians tend use dos suggest nonpregnant patient . Regarding pregnant patient take enoxaparin dalteparin , American College Obstetricians Gynecologists state `` lack data regard adequate dosing pregnancy , anti-factor Xa level may monitor '' . Two recently publish study demonstrate plasma anti-factor Xa level pregnancy low expect , indicate many pregnant patient may receive subprophylactic dosing . Our objective check pregnancy outcome among thrombophilic woman treat adjusted enoxaparin thromboprophylaxis dosage accord anti-factor Xa plasma level compare woman fix dosage .</brief_summary>
	<brief_title>Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According Anti-factor Xa Plasma Levels Improve Pregnancy Outcome</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Pre-Eclampsia</mesh_term>
	<mesh_term>Fetal Growth Retardation</mesh_term>
	<mesh_term>Fetal Death</mesh_term>
	<mesh_term>Abruptio Placentae</mesh_term>
	<criteria>WOMEN WITH Singleton gestation A history fetal demise , fetal growth restriction , placental abruption , preeclampsia , recurrent abortion maternal thromboembolic event . Acquired congenital thrombophilia treat low molecular weight heparin Women treat empirically low molecular weight heparin Women history pregestational diabetes . Significant polyhydramnios oligohydramnios , major fetal structural , generic chromosomal malformation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>placental syndrome</keyword>
	<keyword>maternal thromboembolic event</keyword>
	<keyword>enoxaparin</keyword>
	<keyword>anti-factor Xa</keyword>
</DOC>